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Objectives: Osteoporosis and fracture impose a significant health care burden on the contemporary
populations in developing countries. The Vietnam Osteoporosis Study (VOS) sought to assess the burden
of osteoporosis and its comorbidities in men and women.
Methods: The study was designed as a population-based family investigation in which families were
randomly recruited from Ho Chi Minh City, Vietnam. Individuals were assessed for bone health, including
bone mineral density (BMD) and body composition and trabecular and cortical bone properties by pQCT
(peripheral quantitative computed tomography). Fasting blood samples were obtained for the analysis of
plasma glucose, glycosylated hemoglobin, and bone turnover markers. Genomic DNA extraction from
whole blood samples for further genetic and genomic analyses.
Results: We have recruited more than 4157 individuals from 817 families. The average age of participants
was 51, with approximately 45% of the individuals aged 50 years and older. Approximately 3% of par-
ticipants were obese (body mass index  30 kg/m2), and 21% were overweight. Notably, 11% of partic-
ipants aged 40 years and older were diabetic. Among those aged 50 years and older, approximately 14%
of women and 5% of men had osteoporosis (i.e., femoral neck BMD T-scores  2.5). There were modest
correlations between volumetric BMD and areal BMD.
Conclusions: VOS is a major bone research project in Vietnam aimed at comprehensively documenting
the burden osteoporosis, its co-occurrence of chronic diseases, and their underlying etiologies. The Study
will make important contributions to the literature of bone health worldwide.
© 2017 The Korean Society of Osteoporosis. Publishing services by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Osteoporosis and its consequence of fragility are increasingly
recognized as a major public health burden in contemporary pop-
ulations. It is highly prevalent among the elderly of both genders. In
the Caucasian populations, the lifetime risk of fracture is about 50%
for women and 30% for men [1]. In women, the lifetime risk of hip
fracture is higher than the lifetime risk of having invasive breast
cancer [2]. Moreover, for women aged 50 years, their risk of death
related to a hip fracture is equivalent to their risk of death from
breast cancer and 4 times greater than that from endometrial
cancer [3]. Currently, due to lack of prospective studies, no data onh Laboratory, Ton Duc Thang
, Ho Chi Minh City, Viet Nam.
o-Pham).
ociety of Osteoporosis.
osis. Publishing services by Elsevthe lifetime risk of fracture in Asian populations are available.
However, it is expected that with the ongoing increase in ageing in
Asian populations, the burden of osteoporosis is expected to in-
crease in the near future.
Another important aspect of osteoporosis is that patients with a
pre-existing fracture are at increased risk of refractures [4] and
mortality [5]. Indeed, among individuals with an incident fracture,
the risk of a refracture is increased by 30%e40% within 3 years [5].
However, more disturbingly, fracture is associated with reduced life
expectancy or increased risk of premature mortality, with men
having higher risk of death than women [6]. The 5-year post-
fracture cumulative survival probability for men and women were
48% and 59%, respectively. Approximately one-fifth of patients with
hip fracture diewithin 12months after the event [7], and the 5-year
cumulative survival probability was 63%. These data collectively
indicate that osteoporotic fracture, particularly hip fracture, is a
serious condition because it is associated with increased risk of
death, a fact that is not well known within the primary careier B.V. This is an open access article under the CC BY-NC-ND license (http://
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Vietnam, a developing country in Southeast Asia, is an ideal
setting for studying osteoporosis. The country has a population of
92 million, with per capita gross domestic product being ~2000
United States dollar. The population is undergone ageing, with in-
crease in the proportion of people aged 60 years and above. The
country is in the stage of rapid urbanization with significant
changes in lifestyle factors. Thus, there is an increasing interest in
the epidemiology of osteoporosis in Vietnam. In a recent study in
Vietnam, we have estimated that approximately 29% of women
aged 50 þ years had osteoporosis [8] and about 28% of them have
vertebral fractures [9]. These data show that the magnitude of
osteoporosis in Vietnam is similar to that in other countries in Asia
and in the West.
Osteoporosis has a complex pathophysiology. The susceptibility
to osteoporosis and its consequence of fracture is determined by
factors related to hormone, lifestyle, environmental exposures, and
genetics. Osteoporotic patients usually have comorbidities that are
mostly associated with osteoporosis such as obesity, diabetes, car-
diovascular disease, metabolic syndrome and osteoarthritis. These
complex noncommunicable diseases (NCDs) are characterized by
deterioration in multiple dimensions also related to lifestyle, ge-
netics and hormones. Thus, osteoporosis and these chronic diseases
are linked in a networking manner through the genetic factors that
can be referred to as “diseasome.” In the Wnt pathway alone, on
average each disease shared ~15 neighbors with each other disease,
indicating high comorbidity within the network [10].
Vietnam has also undergone remarkable changes in disease
burdens parallel with the economic development. Indeed, the
prevalence of NCDs is rapidly increasing. According to a recent
report, NCDs collectively account for 71% of total burden of disease
in Vietnam, including 60% of all-cause deaths [11]. Compared with
two decades ago, the disease burden attributable to NCDs repre-
sents a 30% increase. As a result, osteoporotic fracture, which is
usually associated with comorbidity NCDs, has an increase in
mortality risk. However, the burden of and risk factors for osteo-
porotic fractures and comorbidity NCDs have not been well docu-
mented in Vietnam and a complete map of interassociations
between chronic morbidities and osteoporosis has not been
developed.
The hypothesis underlying the present study is that osteopo-
rosis and its multimorbidity NCDs share genes, their encoded
proteins and pathways that stratify patients in subgroups and their
tendency to co-occur together. The overall goal of VOS is to map
genetic and environmental factors that underlie the risk of fragility
fracture and the co-occurrence of related chronic diseases (i.e., the
so-called “diseasome”) in the Vietnamese people.
We pursue the following specific aims: (1) to assess the skeletal
burden and its associatedmorbidities in the general population.We
aim to estimate the prevalence of osteoporosis, osteoarthritis and
multimorbidity, the incidence of fragility fractures and osteoar-
thritis inmen andwomen by age group; (2) to determine the extent
to which variation in osteoporosis, fracture and osteoarthritis sus-
ceptibility is determined by genetic factors. We also aim to identify
genetic variants that are associated with osteoporosis, fracture and
osteoarthritis; (3) to understand the interplay between genes and
environmental factors in the determination of the association be-
tween osteoporosis and other chronic diseases, NCDs including
osteoarthritis, sarcopenia, obesity, diabetes, metabolic syndrome,
and cardiovascular disease.
This project will contribute significant new information on the
genetic and environmental bases of osteoporosis and related
chronic diseases. The project will also contribute to the knowledge
on the specific genes that underline the between subject variation
in skeletal parameters.2. Methods
2.1. Study design
The study is designed as a population based family study. Par-
ticipants were drawn frommultiple families who were living in Ho
Chi Minh City and rural areas. The study's procedure and protocol
were approved by the research and ethics committee of the Peo-
ple's Hospital 115 on August 6, 2015 (approval number: 297/BV-
NCKH). The Studywas conducted according to the ethical principles
of the Declaration of Helsinki, and all participants gave written
informed consent.
We used 2 approaches to recruit participants. In the first
approach, we contacted community organizations to solicit a list of
members, and from the list we ran a computer program to
randomly selected individuals who met the age and sex criteria. A
letter was then sent to the selected individuals to invite them and
their family members to participate in the Study. In the second
approach, we recruited participants via television, the Internet, and
flyers in universities. The flyers described (in Vietnamese) the
study's purposes, procedures, and benefits of participants. In-
dividuals agreed to participate in the study were then transported
to the Bone and Muscle Research Laboratory at the Ton Duc Thang
University for clinical assessment and evaluation. The participants
do not receive any financial incentive, but they received a free
health check-up, and lipid analyses.
The inclusion criteria were broad: men and women aged be-
tween 18 years and older, who agreed to participate in the study.
We excluded individuals deemed to have impaired cognitive
function or are not willing to give informed consent or were
physically unable to complete clinical tests. The participants will
then be followed for 10 years to record the incidence of fractures
and chronic diseases.
2.2. Measurements
Extensive data were collected at baseline. Each participant was
administered with a structured questionnaire by a trained inter-
viewer. The questionnaire solicits information concerning their
demographic factors, clinical history, medication use, lifestyle fac-
tors, physical activity, dietary habits, history of falls and fractures,
and anthropometric factors.
2.2.1. Anthropometry
Height and weight were measured by an electronic portable,
wall-mounted stadiometer (Seca Model 769; Seca Corp., CA, USA)
without shoes or ornaments or hats or heavy layers of clothing.
Body mass index (BMI) was derived as the weight in kilograms
divided by the square of the height in meters. We classified the BMI
into 4 groups as follows: underweight (if BMI < 17 kg/m2); normal
(BMI between 17 and 22 kg/m2); overweight (BMI between 23 and
27.4 kg/m2); and obese (BMI > 27.4 kg/m2).
Waist circumference (WC) and hip circumference (HC)were also
measured in each participant by using the World Health Organi-
zation (WHO) protocol [12]. HC was measured around the widest
portion of the buttocks (in standing position) by using a measuring
tape. WC was measured at the midpoint between lower margin of
the least palpable rib and the top of the iliac crest. Waist to hip ratio
(WHR) was derived as the ratio of WC over HC. Central obesity was
defined as WHR > 0.85 for women or >0.90 for men.
2.2.2. Lifestyle data
Participants were also asked to provide information on current
and past smoking habits. Cigarette smoking was classified into 2
broad groups: past smoking and current smoking. In addition, the
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years by multiplying the number of years smoked with the average
number of packs per day.
Alcohol intake in average numbers of standard drinks per day, at
present as well as within the last 5 years, was obtained. Drinks per
interval was estimated by multiplying quantity by frequency for
days of the week and more than usual and adding. The alcohol
intake was quantified by the number of years alcohol consumed,
number of drinks per day during the drinking years (total number
of drinks/total number of days in drinking years), number of drinks
per drinking day (total number of drinks/total number of days on
which alcohol was consumed in drinking years). In addition, we
also ascertain tea and soft drink intakes by using the same method
of quantification as used in the ascertainment of alcohol intakes.
Physical activity was measured based on the WHO Stepwise
Approach to Surveillance (Steps) of Non-Communicable Disease
Risk Factors [13], the validated questionnaire is built with 15
questions to collect data of the time spending for work, traveling to
and from places, recreational activities and sedentary behavior in a
typical week.
Clinical data including blood pressure, pulse, and reproductive
history (i.e., parity, age of menarche, and age of menopause),
medical history (i.e., previous fracture, previous and current use of
pharmacological therapies) were also obtained. Two blood pressure
measurements were taken (5 min apart) in seated position, and the
mean of 2 measurements was taken as the individual's blood
pressure. Individuals were classified as having hypertension if their
average systolic blood pressure 140 mmHg or diastolic blood
pressure 90 mmHg.
2.3. Skeletal assessments
2.3.1. Bone mineral density
Areal BMD was measured at the lumbar spine, femoral neck,
total hip and whole body using a Hologic Horizon (Hologic Corp.,
Bedford, MA, USA). For the lumbar spine, we measured BMD from
L2 to L4. The densitometer was standardized by phantom before
each measurement. The measurement was done by a qualified
radiology technologist. Based on 20 individuals, the coefficient of
variation in BMD at our lab was 1.5% for the lumbar spine and 1.7%
for the hip. Fat mass and lean mass were derived from the whole
body scan.
2.3.2. Diagnosis of osteoporosis
Based on the femoral neck BMD measurement, we calculated
the sex-specific T-score using our reference data on peak BMD that
has been published previously [8]. Based on the T-score, we classify
individuals into 3 groups according to the WHO's criteria: (1)
osteoporosis, if the T-score is equal to or lower than 2.5; (2)
osteopenia, if T-score is between 1 and 2.5; and (3) normal, if T-
score is equal or greater than 1.
Trabecular bone score (TBS) was performed by the TBS iNsight
Software, version 2.1 (Medimaps, Merignac, France). These analyses
were performed blind to fracture status and any clinical parame-
ters. The software uses the anterior-posterior spine raw image(s)
from the densitometer, including the BMD region of interest and
edge detection so that the TBS calculation is performed over exactly
the same region of interest as the BMDmeasurement. In the current
analysis, we used a research version of the commercialized TBS
iNsight software, which allows for large batched analyses from a
workstation. The short-term coefficient of variation in TBS de-
terminations has been reported in several mono-center studies
ranges from 1.1% to 1.9% [14].
Hip geometrical measures including hip axis length, were
derived from the femoral neck scan. Calculation of geometryparameters for the neck, shaft, and intertrochanteric regions with
narrow neck across the narrowest diameter of the (1) femoral neck,
(2) intertrochanteric along the bisector of the neck-shaft angle, and
(3) the shaft, 2 cm distal to the midpoint of the lesser trochanter.
For each region the distribution of the bone mass across the bone is
extracted then geometry properties are derived as follows:
 Cross sectional area (mm2): equivalent to the amount of (cortical
equivalent) bone surface area in the cross-section after
excluding all trabecular and soft tissue spaces.
 Cross sectional moment of inertia (mm4): for bending in the
image plane from bone mass profile integral.
Index of structural rigidity; reflects distribution of mass about
the center of a structural element.
 Section modulus (mm3): indicator of bending strength for
maximum bending stress in the image plane.
 Buckling ratio: relative thickness of narrow neck cortex as an
estimate of cortical stability in buckling.2.3.3. pQCT measurements
We used a peripheral quantitative computer tomography
(pQCT) XCT3000 (Stratec Medizintechnik GmbH, Pforzheim, Ger-
many) to measure bone volume and bone geometry including the
cortical (outer shell) and trabecular (inner spongy bone) com-
partments of the tibia and radius. The following parameters were
obtained from the pQCT:
 Volumetric bone mineral density (vBMD)
 Cross-sectional area
 Cortical thickness, endocortical (inner side of the cortical shell)
 Periosteal (outer side of the cortical shell) circumference
 Section modulus (mm3)
 Cross-sectional and polar moment of inertia (CSMI and PMI):
CSMI is an estimation of the resistance of bone to bending,
whereas PMI represents the ability of bone to resist torsion
 Strength-strain index which relates to bending and torsional
strength of the bone.
2.4. Radiographic evaluation
Anteroposterior and oblige digital X-ray (FCR Capsula XLII,
Fujifilm Corp., Tokyo, Japan) of the hands, knee, hip and spine were
obtained from each participant. The assessment of osteoarthritis is
based on the Kellgren-Lawrence scoring system which is recom-
mended by the WHO as a standard method for studying in large
epidemiologic studies. The radiographs are read by 2 experienced
rheumatologist who are unaware of the clinical conditions of par-
ticipants. In each area (e.g., knee, wrist, and hip), the presence or
absence of osteophytes, joint space narrowing, sclerosis and cysts is
examined for each hand joint using the Kellgren-Lawrence system
of scoring: 0, none; 1, possible osteophytes only; 2, definite
osteophytes and possible joint space narrowing; 3, multiple
osteophytes, definite joint space narrowing and possible bony
deformity; and 4, large osteophytes, severe joint space narrowing,
severe sclerosis and definite bony deformity. The presence of
radiographic osteoarthritis is defined if the grade is 2 or more in at
least one joint.
2.5. Muscle strength assessment
A hand dynamometer (Baseline Hand Dynamometer - HiRes
Gauge - ER 300 lb. Capacity, 3B Scientific, Atlanta, GA, USA) was
used to measure the strength of both right and left hands for all
participants. Moreover, back and feet strengths were measured by
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Oversize Platform - 660 lb. Capacity, 3B Scientific). Results of
measurement were calculated by kg unit, with the smallest
measuring value is 0.1 kg and 0.5 kg for hand and back, respectively.
Each individual was measured twice, and the highest value was
used for the analysis.
Muscle function motion analysis, performance analysis and
fitness test were measured by Leonardo mechanograph GRFP
(Stratec). The parameters include:
 Individual performance (anearobic peak power, Esslinger
Fitness Index, EFI: W/kg body weight normalized to gender and
age from 2 to 99 years)
 Individual maximum voluntary force per leg
 Individual performance during chair rising test
 Maximum isometric grip forceTable 1
Age and sex distribution in the Vietnam Osteoporosis Study.
Age group, yr Women (n ¼ 2699) Men (n ¼ 1458)
18e29 352 (13.0) 294 (20.2)
30e39 317 (11.7) 228 (15.6)
40e49 609 (22.6) 284 (19.5)
50e59 833 (30.9) 396 (27.2)
60e69 416 (15.4) 186 (12.8)
70e99 172 (6.4) 70 (4.8)
Values are presented as number (%).2.6. Carotid intima-media thickness
The intima media thickness were measured with Philips Ultra-
sound machine e model HD7XE with a 7 MHz linear transducer.
These measurements were made at the common carotid artery,
carotid bulb, and the proximal internal carotid artery of both side.
All images were stored as DICOM format for analysis. Intima-media
thickness values of more than 0.9 mm (European Society of Car-
diology) or over the 75% (American Society of Echocardiography)
were considered abnormal.
2.7. Laboratory analyses
Fasting venous blood sample (12 mL) was taken from each
participant by venipuncture between 7 AM and 11 AM. The serum
was immediately frozen to 20C prior to biochemical analysis
which was taken within 24 hours after the collection.
2.7.1. Glycemia measurements
Glycosylated hemoglobin (HbA1c) levels were measured with
high pressure liquid chromatography (HPLC) analyzers ADAMS A1c
HA-8160 (Arkray, Kyoto, Japan). The intra- and interassay coeffi-
cient of variation for this HPLC is less than 1%. Fasting plasma
glucose (FPG) levels were determined by the hexokinase method
(Advia 1800 Autoanalyzer; Bayer Diagnostics, Leverkusen, Ger-
many) with an intra-measurement coefficient of variance of 0.98%e
1.34%.
An individual was diagnosed to have diabetes if the individual's
HbA1c value 6.5% (48 mmol/mol) [15]. Prediabetes was defined as
HbA1c value between 5.7% and 6.4% (39e46 mmol/mol) [16]. In
addition and for comparison, diabetes was also diagnosed as in-
dividuals with FPG  7.0 mmol/L, and prediabetes was classified as
FPG between 5.6 and 6.9 mmol/L (i.e., impaired fasting glucose).
2.7.2. Lipid measurements
Total cholesterol, low-density lipoprotein (LDL) cholesterol and
triglycerides were measured by an enzymatic calorimetric test
(Advia 1800, Autoanalyzer; Bayer Diagnostics). The intraassay co-
efficient of variation was 0.6% for cholesterol and 1.6% for tri-
glycerides. All specimens were analyzed at the MEDIC's
Department of Biochemistry and Paraclinical Services (Ho Chi Minh
City, Vietnam). An individual was classified as having “high
cholesterol” if the individual's total cholesterol > 6.2, or LDL
cholesterol > 4.0, or triglycerides >2.2.
2.7.3. Bone turnover markers
The concentration of beta-C-telopeptide (CTX) and procollagentype 1 N-propeptide (P1NP) were analyzed by immunological
techniques electrochemical luminescence on the Roche Elecsys
1010/2010 automated analyzer (Roche Diagnostics GmbH, Man-
nheim, Germany). This analysis method can determine the con-
centration of P1NP within limit of 5e1200 ng/mL, and beta-CTX in
limit of 10e6000 pg/mL. The interassay coefficient of variation was
<20%.
2.7.4. DNA samples
Blood samples will be collected and stored at 80C. DNA was
extracted from leucocytes using either QIAamp DNA Mini Blood Kit
(Qiagen Pty Ltd., Victoria, Australia) or phenol/chloroform.
3. Results
Until now (31/12/2016), 4157 individuals (65% are women) from
more than 817 families have participated in VOS. The distribution of
participants by gender and age group is shown in Table 1. The
average age of both genders was 51, with approximately 53% of
women and 45% of men aged 50 years and older. Key baseline
characteristics are shown in Table 2. The mean BMI of the partici-
pants was 22.8 (standard deviation, 3.4) kg/m2 in women and 23.3
(3.3) kg/m2 in men. Approximately 3% of participants were obese
(BMI  30 kg/m2), and 21% were overweight. A majority of par-
ticipants were married (70% inwomen and 77% in men). A majority
(54%) of the participants had high school education. About 29% of
the women were housewives, and 12% of men were retirees. In
men, 41% were self-reported current smokers, and 45% were reg-
ular alcohol drinkers.
Among those aged 50 years and older, approximately 14% of
women and 5.3% of men had osteoporosis (i.e., femoral neck BMD
T-scores  2.5). The prevalence of osteoporosis and osteopenia
increased with advancing age, reaching the highest among those
aged 70 years and older (Table 3). Using the cutoff value of
HbA1c  6.5% (48 mmol/mol), the prevalence of diabetes in women
and men combined was 11%. There was no significant difference in
the prevalence between women and men (P ¼ 0.22). Among the
330 individuals with diabetes, only 125 (38%) were clinically
known to have the disease and were on diabetic treatment.
We measured bone properties (using pQCT) in a subset of 1383
women and 828 men in VOS. The median age of this subset was 47
years (interquartile range, 32e56 years). Descriptive statistics on
pQCT bone parameters are shown in Table 4. As expected, trabec-
ular and cortical bone area, volumetric BMD at the radius and tibia
were greater in men than women. The relationship between age
and vBMD largely followed a quadratic function, with peak level
being reached at the age of 20e30 years. The decline of vBMD
started from the age of 50 years, with women having higher rate of
loss than men (data not shown). At the radius, the rate of loss in
trabecular vBMD was 1.1%/yr in women which was significantly
greater than that in men (0.2%/yr); the rate of loss in cortical vBMD
was 0.3%/yr compared with 0.1%/yr in men. Similar trends were
also observed at the tibia. As expected, polar SSI, SSI, and fracture
Table 2
Marital status, educational level, occupation, and lifestyle factors.
Variable Women (n ¼ 2699) Men (n ¼ 1458)
Height, cm 152.9 ± 5.5 164.1 ± 6.1
Weight, kg 53.2 ± 8.2 62.9 ± 10.1
Body mass index, kg/m2 22.8 ± 3.4 23.3 ± 3.3
BMI category
Underweight 195 (7.2) 82 (5.6)
Normal 1910 (70.8) 962 (66.0)
Overweight 509 (18.9) 370 (25.4)
Obese 85 (3.1) 44 (3.0)
Marital status
Married 1876 (69.5) 1114 (76.5)
Divorced 80 (3.0) 14 (1.0)
Single 572 (21.2) 315 (21.6)
Widowed 170 (6.3) 13 (0.9)
Educational attainment
Some primary schooling 49 (1.8) 7 (0.5)
Primary 591 (21.9) 188 (12.9)
Secondary 1368 (50.7) 800 (55.0)
Tertiary (college and university) 689 (25.5) 459 (31.6)
Occupation
Salespersons 396 (14.7) 208 (14.3)
Officer workers 336 (12.4) 189 (13.0)
Farmers 140 (5.2) 124 (8.5)
Manufacturing workers 135 (5.0) 116 (8.0)
Retirees 237 (8.8) 182 (12.5)
Housewives 768 (28.5) NA
Lifestyle factors
Regular alcohol use 883 (32.7) 653 (44.8)
Current smokers 25 (0.9) 600 (41.2)
Coffee drinking 1077 (40.0) 846 (58.0)
Tea drinking 863 (32.0) 727 (50.0)
NA, not applicable.
Table 4
Descriptive statistics on peripheral quantitative computer tomography bone pa-
rameters by sex.
Variable Women (n ¼ 1383) Men (n ¼ 828)
Tibia 4%
Total bone area, mm2 906 ± 116 1150 ± 138
Total BMC, mg/mm 2.47 ± 0.42 3.50 ± 0.58
Total BMD, mg/mm2 276 ± 48 306 ± 49
Trabecular area, mm2 408 ± 52 517 ± 62
Trabecular BMC, mg/mm 198 ± 39 225 ± 42
Total muscle area, mm2 5591 ± 1222 7396 ± 1503
Tibia 38%
Total bone area, mm2 327 ± 51 417 ± 62
Total BMC, mg/mm 2.67 ± 0.43 3.53 ± 0.54
Total BMD, mg/mm2 821 ± 106 851 ± 86
Polar strength-strain index, mm3 1136 ± 227 1659 ± 332
Strength-strain index X, mm4 707 ± 147 1030 ± 219
Strength-strain index Y, mm3 627 ± 129 944 ± 201
Cortical area, mm2 204 ± 34 273 ± 44
Cortical density, mg/mm2 1179 ± 51 1183 ± 32
Periosteal circumference, mm 63.9 ± 5.3 72.1 ± 5.9
Endosteal circumference, mm 38.8 ± 6.4 42.1 ± 6.3
Total muscle area, mm2 545 ± 84 704 ± 105
Tibia 66%
Total bone area, mm2 456 ± 74 588 ± 94
Total BMC, mg/mm 2.88 ± 0.45 3.77 ± 0.58
Total BMD, mg/mm2 640 ± 98 648 ± 82
Polar strength-strain index, mm3 1958 ± 338 2332 ± 488
Strength-strain index X, mm4 1084 ± 238 1577 ± 337
Strength-strain index Y, mm3 820 ± 174 1236 ± 267
Cortical area, mg/mm2 215 ± 36 285 ± 46
Cortical bone density, mg/mm3 1140 ± 48 1142 ± 29
Cortical thickness, cm 3.34 ± 0.58 3.89 ± 0.60
Periosteal circumference, mm 75.4 ± 6.7 85.6 ± 7.8
Endosteal circumference, mm 54.4 ± 7.9 61.2 ± 8.3
Total muscle area, mm2 8194 ± 1958 9018 ± 1878
Fracture load X, mm4 3903 ± 856 5676 ± 1214
Fracture load Y, mm4 2954 ± 625 4451 ± 962
Radius 4%
Total BMC, mg/mm 0.90 ± 0.17 01.38 ± 0.21
Total bone area, mm2 287 ± 47 375 ± 63
Total BMD, mg/mm3 321 ± 68 374 ± 61
Trabecular area, mm2 129 ± 21 169 ± 28
Trabecular BMD, mg/mm3 153 ± 43 209 ± 51
Total muscle area, mm2 2455 ± 522 3924 ± 757
Radius 38%
Total BMC, mg/mm 0.84 ± 0.20 1.16 ± 0.22
Polar strength strain index, mm3 197 ± 102 306 ± 115
Strength-strain index X, mm3 112 ± 69 174 ± 78
Strength-strain index Y, mm3 119 ± 59 185 ± 60
Total bone area, mm2 124 ± 45 163 ± 40
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of decline in fracture load was not significantly different between
men and women. Areal BMD has a better correlation with trabec-
ular vBMD (r ¼ 0.69) than with cortical vBMD (r ¼ 0.35). Moreover,
the correlation between areal BMD and bone polar strength strain
index or fracture load index was model at either the radius (Fig. 1)
or the tibia (Fig. 2).
We have also analyzed the TBS data from the VOS study [17]. On
average, TBS were 4.5% higher in men than in women. Collectively,
sex, age and height accounted for ~28% of total variance in TBS.
Relative importance analysis indicate that most of the explainedTable 3
Prevalence of osteoporosis, hypertension, and diabetes among individuals aged 40
years and older.
Variable Age group, yr
40e49 50e59 60e69 70e99
Women
Number 609 833 416 172
Osteoporosis 1 (0.2) 56 (6.7) 67 (16.1) 75 (43.6)
Osteopenia 159 (26.1) 431 (51.7) 267 (64.2) 91 (52.9)
Hypertension 106 (17.4) 200 (24.0) 107 (25.7) 56 (32.6)
Diabetes 21 (3.4) 84 (10.1) 75 (18.0) 48 (28.0)
Prediabetes 139 (22.8) 355 (42.6) 216 (51.9) 74 (43.0)
High cholesterol 65 (10.7) 92 (11.0) 49 (11.8) 13 (7.6)
Men
Number 284 396 186 70
Osteoporosis 4 (1.4) 13 (3.3) 7 (3.8) 15 (21.4)
Osteopenia 84 (29.6) 171 (43.2) 111 (60.0) 37 (52.9)
Hypertension 79 (27.8) 122 (34.4) 64 (34.4) 16 (77.1)
Diabetes 14 (4.9) 49 (12.4) 30 (16.1) 9 (12.9)
Prediabetes 94 (33.0) 147 (37.1) 72 (38.7) 38 (54.3)
High cholesterol 40 (14.0) 53 (13.4) 19 (10.2) 6 (8.6)
Values are presented as number (%).
Total BMD, mg/mm3 701 ± 123 722 ± 94
Periosteal circumference, mm 39.0 ± 5.6 45.0 ± 4.9
Endosteal circumference, mm 27.8 ± 6.9 31.0 ± 6.0
Total muscle area, mm2 274 ± 83 371 ± 95
Radius 66%
Total BMC, mg/mm 0.84 ± 0.20 1.16 ± 0.22
Polar strength-strain index, mm3 196 ± 101 306 ± 115
Strength-strain index X, mm3 112 ± 68 174 ± 78
Strength-strain index Y, mm3 119 ± 58 185 ± 61
Total bone area, mm2 123 ± 45 163 ± 40
Total BMD, mg/mm3 701 ± 123 722 ± 94
Periosteal circumference, mm 39.0 ± 5.6 45.0 ± 4.9
Endosteal circumference, mm 27.8 ± 6.9 31.0 ± 6.0
Fracture load X, mm4 404 ± 245 626 ± 281
Fracture load Y, mm4 428 ± 210 667 ± 218
Total muscle area, mm2 3818 ± 692 4797 ± 708
Values are presented as mean ± standard deviation.
BMC, bone mineral content; BMD, bone mineral density.variance was accounted by advancing age. TBS was strongly
correlated with lumbar spine BMD (r ¼ 0.73; P < 0.001). The age
and height adjusted index of heritability of TBSwas 0.46 [17], which
was notmuch different from that of LSBMD (0.44). Furthermore, we
found that the genetic correlation between TBS and LSBMD was
Fig. 1. Correlation between dual-energy X-ray absorptiometry areal bone mineral density (BMD) and peripheral quantitative computer tomography volumetric BMD and bone
strength indices at the radius. FNBMD, femoral neck BMD; LSBMD, lumbar spine BMD; Total.vBMD.4, total volumetric BMD at the 4% site; Total.vBMD.38, total volumetric BMD at
the 38% site; Trab.vBMD4, trabecular vBMD at the 4% site; Cort.vBMD.38, cortical vBMD at the 38% site; Polar.SSI, polar strength-strain index; Fx.Load.X3, fracture load at the 66%
site.
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4. Discussion
Although the prevalence and incidence of, and risk factors for,
osteoporosis and its consequence of fracture are well documented
in Caucasian populations, there are scarce data for Asian pop-
ulations whose burden of hip fracture is expected to account for
30% of hip fractures worldwide [18]. The present VOS is designed to
contribute substantially to the epidemiology and pathogenesis of
osteoporosis in an Asian population. We consider that osteoporosis
should be studied as part of a bigger network of chronic NCDs that
are shared by common environmental and genetic factors. By dis-
secting the contributions of environmental and genetic factors to
the covariation of diseases, we will have a better understanding of
the linkage between osteoporosis and chronic diseases in the
general population.
In this study, we found that the prevalence of osteoporosis
among women and men aged 50 years and older was 14% and ~5%,
respectively. In women, our estimate of osteoporosis prevalence
was lower than that in Koreans [19], but comparable to the National
Health and Nutrition Examination Survey (NHANES) 2005e2006
estimate [20], and the discrepancy was probably due to the skeletal
site used in the classification of osteoporosis. In the Korean study
[19], osteoporosis was defined based on lumbar spine and/or
femoral neck BMD, whereas in our study and NHANES 2005e2006,
the classification of osteoporosis was based on femoral neck BMD
only. In men, our estimate of osteoporosis prevalence was slightly
lower than that in Korean men study which was 7.5% [19], but the
difference was again likely due to the difference in BMD sites.
Among those aged 50 years and older, approximately 14% of
women and 5.3% of men had osteoporosis (i.e., femoral neck BMDT-scores  2.5). The prevalence of osteoporosis and osteopenia
increased with advancing age, reaching the highest among those
aged 70 years and older (Table 3). Using the cutoff value of
HbA1c  6.5% (48 mmol/mol), the prevalence of diabetes in women
and men combined was 11%. There was no significant difference in
the prevalence between women and men (P ¼ 0.22). Among the
330 individuals with diabetes, only 125 (38%) were clinically
known to have the disease and were on diabetic treatment.
Vietnam is an ideal setting for studying osteoporosis and NCDs,
because the country is in a dynamic transition from developing to a
more advanced status. The country's population is about 1.3% of the
world population. The proportion of population living in urban
areas is approximately 30%, and this figure is continuously
increasing. During the past 20 years, the country has continued to
be one of the world's fastest growing economies, with annual
economic growth rate of ~5% [21]. In parallel with the economic
development, Vietnam has also undergone remarkable changes in
disease burdens, and the existence of this trend presents Vietnam
as an ideal setting for studying the dynamic of NCDs in transitional
economies.
While communicable disease still remains a significant burden,
the prevalence of chronic NCDs is rapidly increasing. Currently,
major NCDs include obesity, diabetes, cardiovascular disease, can-
cer, musculoskeletal diseases, including osteoarthritis and osteo-
porosis. Our recent studies suggested that 10% of men and 29% of
women have osteoporosis [8], 36% have knee osteoarthritis [22],
and 12.3%% have type 2 diabetes [23]. The prevalence of diabetes,
mostly undiagnosed, has increased almost 3 fold during the past
two decades. The number of individuals with hypertension has
doubled during the past 2 decades. The prevalence of osteoporosis
and osteoarthritis is equivalent to those found in economically
developed countries [8,22]. Lung cancer alone accounted for more
Fig. 2. Correlation between dual-energy X-ray absorptiometry areal bone mineral density (BMD) and peripheral quantitative computer tomography volumetric BMD and bone
strength indices at the tibia. FNBMD, femoral neck BMD; LSBMD, lumbar spine BMD; Total.vBMD.4, total volumetric BMD at the 4% site; Total.vBMD.38, total volumetric BMD at the
38% site; Trab.vBMD4, trabecular vBMD at the 4% site; Cort.vBMD.38, cortical vBMD at the 38% site; Polar.SSI, polar strength-strain index; Fx.Load.X3, fracture load at the 66% site.
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recent report, NCDs collectively account for 71% of total burden of
disease in Vietnam, including 60% of all-cause deaths [11].
Comparedwith two decades ago, the disease burden attributable to
NCDs represents a 30% increase.
Osteoporosis and many NCDs (e.g., cardiovascular disease, dia-
betes, cancer, and osteoarthritis) to a large extent, share common
risk factors: smoking, excess alcohol intakes, poor nutrition, and
insufficient physical activity. Vietnam is among the countries in the
world that have high prevalence of smoking among men. Our
recent study found that almost 50% of adult men are current
smokers, and about 25% are regular alcohol drinkers. Moreover,
more than 25% of adults are insufficiently active [24]. On the other
hand, energy obtained from fats has doubled in 2 decades. With the
urbanization that is being taken place in the country, the changes in
lifestyle and nutrition are expected to be more pronounced in the
coming years. The sharing of risk factors demands a new and more
systematic approach to the study of osteoporosis, and it is our
vision that VOS will make a contribution to the study of covariation
of NCDs.
The scientific issues of this project are primarily concerned with
environmental influences on osteoporosis. During the past 4 de-
cades or so, the study of determinants of chronic diseases has been
largely focused on the genetic component of disease susceptibility,
and little attention has been on the environmental component. In
reality, genetic effects account for between 15% and 40% of the
variance of disease susceptibility in cancer, cardiovascular disease,
obesity, diabetes and osteoarthritis. Through genomewide associ-
ation studies (GWAS) several genetic variants have been identified
to be associated with cancer, cardiovascular disease, obesity, dia-
betes and osteoarthritis. However, these genetic variants explain
less than 10% of those diseases' variance [25].The above fact, of course, suggests that the variability in oste-
oporosis susceptibility is mainly due to environmental factors.
Environmental factors include, but not limited to, stress, lifestyle
factors, nutritional factors, pollution and pollutants, and chemical
exposures. The totality of environmental factors can be conceptu-
alized as an “exposome” [26], analog of the genome that consists of
genetic variants. By this conceptualization, study of environmental
factors and chronic disease can be analytically based on themethod
of GWAS. With the current technology (i.e., high throughput Gas
Chromatography - Time of Flight mass spectrometry), it is possible
to quantify the total environmental exposure for an individual.
This project proposes a series of analyses and state-of-the-art
technologies to address an important issue: how much variation
in chronic NCDs is attributable to blood exposome and external
environmental factors. The outcome of this analysis can potentially
lead to the development of a new tool for early identification of
high risk individuals and intervention on those components that
are first affected, when reversal may be most possible, and hence
contribute to the healthy aging. An innovative aspect of the project
is the creation of the “diseasome” and exposome that will advance
our understanding of the relationship between multiple comor-
bidities and environmental factors. Thus, the project's outcome also
highlights the impact of environmental factors, including pollution,
to public health in developing countries, and thus helps shape
public health policy.
The findings of this study should of course be interpreted within
the context of strengths and weaknesses. The study was based on a
large, well characterized cohort who was recruited without any
specific criteria that would affect the risk of chronic diseases.
Therefore, our estimates of prevalence of chronic conditions are
unlikely to be affected by selection bias. We have comprehensively
collected a wide range of skeletal phenotypes and clinical
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future diseasome study. However, the study participants were from
a highly urban population; therefore, the findings may not be
generalizable to rural populations.
5. Conclusions
The Vietnam Osteoporosis Study is a major bone health research
project in Vietnam and Asia. The Project will make use of advances
in new scientific disciplines of network medicine, “exposome,” and
genome to develop a unified predictive framework for annotating
the human genome for genetic variants and network of environ-
mental factors (e.g., chemical exposures) that likely contribute to
the co-occurrence of osteoporosis and chronic diseases. We hope
that the outcome of the Study will provide an insight into the
pathogenesis of osteoporosis and its related conditions.
Conflicts of interest
No potential conflict of interest relevant to this article was
reported.
Acknowledgments
This research is funded by Foundation for Science and Tech-
nology Development of Ton Duc Thang University (FOSTECT, http://
fostect.tdt.edu.vn; grant number: FOSTECT.2014.BR.09, and a grant
from the Department of Science and Technology of Ho Chi Minh
City; grant number: YT_2015_03. We sincerely thank Ms Tran Thi
Ngoc Trang and Fr Pham Ba Lam for coordinating the recruitment of
participants. We also thank doctors and medical students of the
PhamNgoc Thach University of Medicine for the data collection and
clinical measurements.
Study team: Dr. Mai Duy Linh, Dr. Doan Cong Minh, Dr. Nguyen
Da Thao Uyen, Dr. Lai Quoc Thai, Dr. Do Minh Tam, Dr. Do Thien An,
Dr. Nguyen Cong Hoang, Dr. Chau Ngoc Minh Phuong, Dr. Nguyen
Trung Thanh, Dr. Bui Dat Thinh, Dr. Nguyen Quynh Thu, Mr. Sam
Vinh Loc, Dr. Bui Van Quoc, Dr. Nguyen Thi Dao Tien, Mr. Tran Xuan
Truong, Ms. Thai Ngoc Tran, Ms Le Thi Phuong Thao, Mr. Nguyen
Van Ngan, Ms. Nguyen Duong Thien Thanh, Mr. Nguyen Truong
Trung Tin, Mr. Nguyen Tan Duc, Mr. Van Hai Long, Ms. Nguyen Le
Phuong Hong, Ms Nguyen Thi Ngoc Yen, Ms. Nguyen Thi Thuy, Ms.
Nguyen Duong Thao Quyen, Mr. Luu Minh Long, Mr. Do Tuan Kiet,
Mr. Nguyen Tam Xuan Kiet, Ms. Nguyen Ngoc Nha Khanh, Mr. Vo
Quang Hung, Mr. Duong Hai, Mr. Chau Quoc Khanh, Mr, Le Vinh
Nghi, Ms Van Thi Ngoc Bich, Ms Tran Thi Nhung.
References
[1] Nguyen ND, Ahlborg HG, Center JR, Eisman JA, Nguyen TV. Residual lifetime
risk of fractures in women and men. J Bone Min Res 2007;22:781e8.
[2] Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet
2002;359:1929e36.
[3] Cummings SR, Black DM, Rubin SM. Lifetime risks of hip, Colles', or vertebralfracture and coronary heart disease among white postmenopausal women.
Arch Intern Med 1989;149:2445e8.
[4] Center JR, Bliuc D, Nguyen TV, Eisman JA. Risk of subsequent fracture after
low-trauma fracture in men and women. JAMA 2007;297:387e94.
[5] Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR. Mortality risk
associated with low-trauma osteoporotic fracture and subsequent fracture in
men and women. JAMA 2009;301:513e21.
[6] Haentjens P, Magaziner J, Colon-Emeric CS, Vanderschueren D, Milisen K,
Velkeniers B, et al. Meta-analysis: excess mortality after hip fracture among
older women and men. Ann Intern Med 2010;152:380e90.
[7] Frost SA, Nguyen ND, Center JR, Eisman JA, Nguyen TV. Excess mortality
attributable to hip-fracture: a relative survival analysis. Bone 2013;56:23e9.
[8] Ho-Pham LT, Nguyen UD, Pham HN, Nguyen ND, Nguyen TV. Reference ranges
for bone mineral density and prevalence of osteoporosis in Vietnamese men
and women. BMC Musculoskelet Disord 2011;12:182.
[9] Ho-Pham LT, Mai LD, Pham HN, Nguyen ND, Nguyen TV. Reference ranges for
vertebral heights and prevalence of asymptomatic (undiagnosed) vertebral
fracture in Vietnamese men and women. Arch Osteoporos 2012;7:257e66.
[10] Nayak L, Tunga H, De RK. Disease co-morbidity and the human Wnt signaling
pathway: a network-wise study. OMICS 2013;17:318e37.
[11] Harper C. Vietnam noncommunicable disease prevention and control pro-
gramme 2002-2010. WHO Report 2011. Geneva: World Health Organization;
2011.
[12] World Health Organization. Waist circumference and WaisteHip ratio: report
of a WHO expert consultation. WHO Tehnical Report 2011. Geneva: World
Health Organization; 2011.
[13] Bonita R, Winkelmann R, Douglas KA, de Courten M, The WHO. Stepwise
approach to surveillance (STEPS) of non-communicable disease risk factors.
In: McQueen DV, Puska P, editors. Global behavioral risk factor surveillance.
New York: Kluwer Academic/Plenum Publishers; 2003. p. 9e22.
[14] Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, et al. Trabecular
bone score: a noninvasive analytical method based upon the DXA image.
J Bone Min Res 2014;29:518e30.
[15] International Expert Committee. International Expert Committee report on
the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:
1327e34.
[16] American Diabetes Association. Diagnosis and classification of diabetes mel-
litus. Diabetes Care 2010;33(Suppl 1):S62e9.
[17] Ho-Pham LT, Hans D, Doan MC, Mai LD, Nguyen TV. Genetic determinant of
trabecular bone score (TBS) and bone mineral density: a bivariate analysis.
Bone 2016;92:79e84.
[18] Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, et al. Secular
trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int
2011;22:1277e88.
[19] Choi YJ, Oh HJ, Kim DJ, Lee Y, Chung YS. The prevalence of osteoporosis in
Korean adults aged 50 years or older and the higher diagnosis rates in women
who were beneficiaries of a national screening program: the Korea National
Health and Nutrition Examination Survey 2008-2009. J Bone Min Res
2012;27:1879e86.
[20] Looker AC, Melton 3rd LJ, Harris TB, Borrud LG, Shepherd JA. Prevalence and
trends in low femur bone density among older US adults: NHANES 2005-2006
compared with NHANES III. J Bone Min Res 2010;25:64e71.
[21] The World Bank. Science, technology and innovation in Vietnam. OECD re-
views of innovation policy 2014. Washington, DC: The World Bank; 2014.
[22] Ho-Pham LT, Lai TQ, Mai LD, Doan MC, Pham HN, Nguyen TV. Prevalence of
radiographic osteoarthritis of the knee and its relationship to self-reported
pain. PLoS One 2014;9. e94563.
[23] Ho-Pham LT, Do TT, Campbell LV, Nguyen TV. HbA1c-Based classification re-
veals epidemic of diabetes and prediabetes in Vietnam. Diabetes Care
2016;39:e93e4.
[24] The World Bank. World development indicators [Internet]. Washington, DC:
The World Bank; 2017 [cited 2017 Jan 13]. Available from: http://databank.
worldbank.org/data/views/reports/tableview.aspx.
[25] Estrada K, Styrkarsdottir U, Evangelou E, Hsu YH, Duncan EL, Ntzani EE, et al.
Genome-wide meta-analysis identifies 56 bone mineral density loci and re-
veals 14 loci associated with risk of fracture. Nat Genet 2012;44:491e501.
[26] Wild CP. Complementing the genome with an “exposome”: the outstanding
challenge of environmental exposure measurement in molecular epidemi-
ology. Cancer Epidemiol Biomark Prev 2005;14:1847e50.
